News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
412,597 Results
Type
Article (27730)
Company Profile (116)
Press Release (384747)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (102278)
Career Advice (545)
Deals (18049)
Drug Delivery (91)
Drug Development (38947)
Employer Resources (80)
FDA (10905)
Job Trends (10028)
News (176082)
Policy (20869)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (2122)
Academic (2)
Accelerated approval (21)
Adcomms (16)
Allergies (92)
Alliances (28681)
ALS (88)
Alzheimer's disease (1110)
Antibody-drug conjugate (ADC) (154)
Approvals (11216)
Artificial intelligence (363)
Autoimmune disease (83)
Automation (20)
Bankruptcy (148)
Best Places to Work (9006)
BIOSECURE Act (8)
Biosimilars (156)
Biotechnology (59)
Bladder cancer (103)
Brain cancer (35)
Breast cancer (358)
Cancer (2550)
Cardiovascular disease (288)
Career advice (508)
Career pathing (14)
CAR-T (117)
CDC (51)
Cell therapy (365)
Cervical cancer (26)
Clinical research (34114)
Collaboration (1061)
Compensation (151)
Complete response letters (22)
COVID-19 (2304)
CRISPR (52)
C-suite (504)
Cystic fibrosis (88)
Data (3765)
Decentralized trials (2)
Denatured (21)
Depression (108)
Diabetes (342)
Diagnostics (5161)
Digital health (45)
Diversity (10)
Diversity, equity & inclusion (24)
Drug discovery (137)
Drug pricing (169)
Drug shortages (12)
Duchenne muscular dystrophy (129)
Earnings (36249)
Editorial (40)
Employer branding (8)
Employer resources (73)
Events (76260)
Executive appointments (661)
FDA (13077)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1038)
Gene editing (99)
Generative AI (34)
Gene therapy (288)
GLP-1 (594)
Government (4392)
Grass and pollen (6)
Guidances (284)
Healthcare (15092)
HIV (52)
Huntington's disease (18)
IgA nephropathy (49)
Immunology and inflammation (111)
Immuno-oncology (29)
Indications (73)
Infectious disease (2548)
Inflammatory bowel disease (124)
Inflation Reduction Act (16)
Influenza (109)
Intellectual property (114)
Interviews (59)
IPO (7792)
IRA (40)
Job creations (1412)
Job search strategy (450)
JPM (60)
Kidney cancer (4)
Labor market (40)
Layoffs (213)
Leadership (11)
Legal (3939)
Liver cancer (57)
Longevity (12)
Lung cancer (315)
Lymphoma (203)
Machine learning (20)
Management (30)
Manufacturing (407)
MASH (107)
Medical device (9628)
Medtech (9672)
Mergers & acquisitions (10937)
Metabolic disorders (852)
Multiple sclerosis (113)
NASH (10)
Neurodegenerative disease (186)
Neuropsychiatric disorders (61)
Neuroscience (1888)
Neurotech (1)
NextGen: Class of 2026 (4994)
Non-profit (3949)
Now hiring (13)
Obesity (393)
Opinion (159)
Ovarian cancer (81)
Pain (111)
Pancreatic cancer (90)
Parkinson's disease (158)
Partnered (21)
Patents (221)
Patient recruitment (280)
Peanut (32)
People (33703)
Pharmaceutical (31)
Pharmacy benefit managers (29)
Phase 1 (10807)
Phase 2 (13400)
Phase 3 (12137)
Pipeline (3367)
Policy (242)
Postmarket research (1574)
Preclinical (3463)
Press Release (47)
Prostate cancer (143)
Psychedelics (38)
Radiopharmaceuticals (170)
Rare diseases (536)
Real estate (2876)
Recruiting (33)
Regulatory (15602)
Reports (25)
Research institute (1964)
Resumes & cover letters (40)
Rett syndrome (20)
RNA editing (6)
RSV (65)
Schizophrenia (108)
Series A (162)
Series B (134)
Service/supplier (4)
Sickle cell disease (73)
Special edition (11)
Spinal muscular atrophy (95)
Sponsored (28)
Startups (2113)
Stomach cancer (4)
Supply chain (71)
Tariffs (47)
The Weekly (44)
Vaccines (849)
Venture capital (68)
Weight loss (240)
Women's health (83)
Worklife (7)
Date
Today (72)
Last 7 days (365)
Last 30 days (1348)
Last 365 days (18764)
2026 (1986)
2025 (19085)
2024 (21792)
2023 (24262)
2022 (33691)
2021 (37126)
2020 (37576)
2019 (33257)
2018 (24880)
2017 (17708)
2016 (18858)
2015 (21430)
2014 (16062)
2013 (12721)
2012 (13464)
2011 (13906)
2010 (11929)
Location
Africa (531)
Alabama (35)
Alaska (6)
Arizona (184)
Arkansas (11)
Asia (22437)
Australia (3970)
California (6230)
Canada (2180)
China (618)
Colorado (307)
Connecticut (334)
Delaware (191)
Europe (50443)
Florida (988)
Georgia (262)
Hawaii (2)
Idaho (39)
Illinois (601)
India (56)
Indiana (452)
Iowa (13)
Japan (296)
Kansas (89)
Kentucky (27)
Louisiana (24)
Maine (79)
Maryland (949)
Massachusetts (4635)
Michigan (220)
Minnesota (401)
Mississippi (3)
Missouri (121)
Montana (18)
Nebraska (20)
Nevada (93)
New Hampshire (59)
New Jersey (2165)
New Mexico (12)
New York (1950)
North Carolina (966)
North Dakota (4)
Northern California (3118)
Ohio (219)
Oklahoma (13)
Oregon (28)
Pennsylvania (1436)
Puerto Rico (12)
Rhode Island (29)
South America (681)
South Carolina (34)
South Dakota (1)
Southern California (2357)
Tennessee (138)
Texas (945)
United States (24585)
Utah (265)
Virginia (144)
Washington D.C. (53)
Washington State (602)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
412,597 Results for "lyra health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lyra Therapeutics Provides Corporate Update
January 12, 2026
·
4 min read
Press Releases
Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
·
9 min read
Press Releases
Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study
October 6, 2025
·
7 min read
Press Releases
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 12, 2025
·
13 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Business
Lyra Therapeutics Announces Cost-Cutting Measures to Preserve Capital
Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that it is advancing its goal to preserve capital by implementing a layoff of approximately 75% of its workforce, in addition to other cost-cutting measures.
May 21, 2024
·
8 min read
Press Releases
Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 7, 2025
·
10 min read
Drug Development
Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic Rhinosinusitis
Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced topline results from the Company’s Phase 3 ENLIGHTEN 1 trial evaluating LYR-210 for the treatment of chronic rhinosinusitis (CRS).
May 6, 2024
·
8 min read
Press Releases
SiPhox Health Introduces a Smarter Way of Health Tracking From Home
February 3, 2026
·
1 min read
1 of 41,260
Next
